![Alberto Gimona](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alberto Gimona
No open positions remaining
Net worth: - $ as of 2026-08-30
Profile
Alberto Gimona worked at Actelion Ltd. from 2011 to 2017 as Head-Clinical Science.
From 2019 to 2026, Dr. Gimona worked at Idorsia Ltd., serving as Head-Global Clinical Development & Executive VP from 2022 to 2026.
Dr. Gimona earned a doctorate from the University of Pisa.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IDORSIA LTD. -.--% | 2024-12-30 | 0 ( -.--% ) | - $ | 2026-08-30 |
Former positions of Alberto Gimona
| Companies | Position | End |
|---|---|---|
| IDORSIA LTD | Corporate Officer/Principal | 2026-04-30 |
| ACTELION | Chief Tech/Sci/R&D Officer | 2016-12-31 |
Training of Alberto Gimona
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
39
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs | Health Technology |
University of Pisa
 University of Pisa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Idorsia Ltd.
 Idorsia Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of medicines for unmet medical needs | Health Technology |
- Stock Market
- Insiders
- Alberto Gimona
